MAPT and Alzheimer disease: Our studies add to this body of evidence and further suggest a possible mechanism supporting a link with serotonin and AD (22) by showing that the metabolic product of serotonin, 5-HIAA, which is depleted in AD (23), is a phenol-type tau inhibitor.